Ongoing Pregnancy Rates with Daily Recombinant Follicle-Stimulating Hormone/Gonadotropin-Releasing Hormone Antagonist Protocol in a Large North American Cohort of In Vitro Ferlilization/Intracytoplasmic Sperm Injection Patients by Day of Embryo Transfer.

被引：0
|
作者：
Lifchez, A. [1 ]
Nagy, Z. P. [2 ]
Witjes, H. [3 ]
Mannaerts, B. [3 ]
Gordon, K. [4 ]
Mahony, M. [4 ]
机构：
[1] Fertil Ctr Illinois, SC, Chicago, IL USA
[2] Reprod Biol Associates, Atlanta, GA USA
[3] Schering Plough Corp, Schering Plough Res Inst, Oss, Netherlands
[4] Schering Plough Corp, Kenilworth, NJ USA
来源：
FERTILITY AND STERILITY | 2010年 / 93卷 / 05期
关键词：
D O I：
10.1016/j.fertnstert.2010.01.100
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 39 条
  • [21] Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis
    Yujing Xiong
    Zhiqin Bu
    Wei Dai
    Meixiang Zhang
    Xiao Bao
    Yingpu Sun
    Reproductive Biology and Endocrinology, 12
  • [22] A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol
    Hohmann, FP
    Macklon, NS
    Fauser, BCJM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01): : 166 - 173
  • [23] Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles
    Seow, Kok-Min
    Lin, Yu-Hung
    Huang, Lee-Win
    Hsieh, Bih-Chwen
    Huang, Shih-Chia
    Chen, Chin-Yu
    Chen, Pei-Hsin
    Tzeng, Chii-Ruey
    Hwang, Jiann-Loong
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (06) : 338 - 342
  • [24] Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients
    Hompes, Peter G. A.
    Broekmans, Frank J.
    Hoozemans, Diederik A.
    Schats, Roel
    FERTILITY AND STERILITY, 2008, 89 (06) : 1685 - 1693
  • [25] A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol -: Response
    Fauser, BCJM
    Macklon, NS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09): : 4510 - 4511
  • [26] Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone
    Cabrera, RA
    Stadtmauer, L
    Mayer, JF
    Gibbons, WE
    Oehninger, S
    FERTILITY AND STERILITY, 2005, 83 (01) : 42 - 48
  • [27] Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study
    Golbasi, Hakan
    Ince, Onur
    Golbasi, Ceren
    Ozer, Mehmet
    Demir, Mustafa
    Yilmaz, Bulent
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 39 (02) : 157 - 163
  • [28] Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With "Unpredictable" Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol
    Zhang, Chunhui
    Wu, Fangrong
    Wu, Zexuan
    Sun, Bolan
    Chen, Cheng
    Qian, Weiping
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [29] Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)
    de Jong, D
    Macklon, NS
    Eijkemans, MJC
    Mannaerts, BMJL
    Bennink, HJTC
    Fauser, BCJM
    FERTILITY AND STERILITY, 2001, 75 (04) : 688 - 693
  • [30] Intrafollicular antimullerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer
    Dumesic, Daniel A.
    Lesnick, Timothy G.
    Stassart, Jacques P.
    Ball, G. David
    Wong, Ashley
    Abbott, David H.
    FERTILITY AND STERILITY, 2009, 92 (01) : 217 - 221
1234